ICD Lead Noise Detection and Oversensing Mitigation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Implantable cardioverter defibrillators (ICDs) often inaccurately detect tachycardia or fibrillation episodes, leading to inappropriate shock therapies, which can be painful and unnecessary, due to oversensing issues related to lead-related conditions such as oversensing or insulation degradation.
Innovation Solution
The method involves predicting lead-related conditions and determining the likelihood of oversensing, adjusting detection parameters, and withholding therapy if oversensing is detected, using a combination of sensing integrity counters, impedance trend monitoring, and electrogram analysis to reduce inappropriate shock deliveries.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If the ICD uses standard detection parameters to identify tachycardia or fibrillation, then it can detect and treat life-threatening arrhythmias, but it may inappropriately detect lead-related noise as cardiac events, leading to unnecessary shock therapies
Solution Approach 1:
The patent introduces an intermediary analysis layer between the raw EGM signal and the therapy delivery decision. This intermediary layer includes algorithms that analyze signal characteristics, detect lead-related conditions through impedance monitoring, and evaluate whether detected events represent true arrhythmias or noise. The intermediary system filters inappropriate detections before they trigger therapy, resolving the contradiction between detecting all potential arrhythmias and avoiding false positives.
Solution Approach 2:
The patent implements preliminary detection and analysis steps before committing to therapy delivery. The system performs preliminary assessments including signal quality evaluation, lead condition monitoring, and arrhythmia verification algorithms that analyze multiple criteria before confirming a true arrhythmia event. This preliminary action allows the system to identify and discard false detections caused by lead-related noise before inappropriate shock therapy is delivered.
2Speed
If the ICD delivers shock therapy immediately upon detecting tachycardia or fibrillation, then it can terminate life-threatening arrhythmias quickly, but it may deliver painful and unnecessary shocks when lead-related noise is misidentified as arrhythmia
Solution Approach 1:
The patent implements preliminary verification steps that occur rapidly after arrhythmia detection but before shock delivery. These preliminary actions include verifying signal consistency across multiple channels, checking for characteristic arrhythmia patterns, assessing lead impedance stability, and evaluating signal morphology. This preliminary verification maintains fast response to true arrhythmias while filtering out false detections caused by lead-related noise.
Solution Approach 2:
The patent incorporates feedback mechanisms where the system continuously monitors multiple parameters including EGM signal characteristics, lead impedance, and detection patterns. When an arrhythmia is detected, the system uses feedback from these monitoring systems to verify the authenticity of the event before committing to therapy delivery. The feedback loop provides rapid confirmation or rejection of arrhythmia detection, enabling fast response to true events while preventing unnecessary shocks from false detections.
Data Source
AI summary
An implantable medical device detects conditions such as a lead failure which may result in oversensing a physiologic condition. In response, the IMD automatically adjusts sensing thresholds, such as the number of intervals to detection in order to mitigate the effect of oversensing in the delivery of extraneous therapy.